Back to RU Rubric Capital Management LP

OVIDOVID

Showing 4 of 14 quarters

Position history for RURubric Capital Management LP's holdings in Ovid Therapeutics Inc.

No. Rubric Capital Management exited its OVID (Ovid Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 478,533 shares worth $157,868. Rubric Capital Management first reported OVID in Q2 2022 and held it in 13 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$5M

Total Shares Change

-5.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$1.30
0
2025-Q2
Decreased
478,533
-91.0%
$157,8680.0%$0.33
0
2025-Q1
Unchanged
5.3M
0.0%
$1.7M0.0%$0.31
0
2024-Q4
Unchanged
5.3M
0.0%
$5M0.1%$0.93
0

Optional analytics helps us improve. How it’s used